{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:29:20Z","timestamp":1791980960200,"version":"4.4.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,2,1]]},"DOI":"10.1093\/jac\/dkh532","type":"journal-article","created":{"date-parts":[[2005,1,14]],"date-time":"2005-01-14T01:18:54Z","timestamp":1105665534000},"page":"188-193","source":"Crossref","is-referenced-by-count":69,"title":["Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital"],"prefix":"10.1093","volume":"55","author":[{"given":"Patricia","family":"Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"S\u00e1nchez-Somolinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Alcal\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Rodr\u00edguez-Cr\u00e9ixems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Pel\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Bouza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,2]]},"reference":[{"key":"key\n\t\t\t\t20171013015916_R1","doi-asserted-by":"crossref","unstructured":"Beck-Sagu\u00e9, C. M. & Jarvis, W. R. & the National Nosocomial Infections Surveillance System (N. N. I. S.). (1993). Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980\u20131990. Journal of Infectious Diseases167, 1247\u201351.","DOI":"10.1093\/infdis\/167.5.1247"},{"key":"key\n\t\t\t\t20171013015916_R2","doi-asserted-by":"crossref","unstructured":"Nolla-Salas, J., Sitges-Serra, A., Leon-Gil, C. et al. (1997). Candidaemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU. Intensive Care Medicine23, 23\u201330.","DOI":"10.1007\/s001340050286"},{"key":"key\n\t\t\t\t20171013015916_R3","doi-asserted-by":"crossref","unstructured":"Walsh, T. J., Hiemenz, J. W. & Anaissie, E. (1996). Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients. Infectious Disease Clinics of North America10, 365\u2013400.","DOI":"10.1016\/S0891-5520(05)70303-2"},{"key":"key\n\t\t\t\t20171013015916_R4","doi-asserted-by":"crossref","unstructured":"Krcmery, V. & Barnes, A. J. (2002). Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. Journal of Hospital Infection50, 243\u201360.","DOI":"10.1053\/jhin.2001.1151"},{"key":"key\n\t\t\t\t20171013015916_R5","doi-asserted-by":"crossref","unstructured":"Abbas, J., Bodey, G. P., Hanna, H. A. et al. (2000). Candida krusei fungaemia. An escalating serious infection in immunocompromised patients. Archives of Internal Medicine160, 2659\u201364.","DOI":"10.1001\/archinte.160.17.2659"},{"key":"key\n\t\t\t\t20171013015916_R6","doi-asserted-by":"crossref","unstructured":"Girmenia, C., Pagano, L., Leone, G. et al. (2001). Fluconazole and Candida krusei fungaemia. Archives of Internal Medicine161, 2267\u20139.","DOI":"10.1001\/archinte.161.18.2267"},{"key":"key\n\t\t\t\t20171013015916_R7","doi-asserted-by":"crossref","unstructured":"Krcmery, V., Jr, Spanik, S., Kunova, A. et al. (1999). Nosocomial Candida krusei fungaemia in cancer patients: report of 10 cases and review. Journal of Chemotherapy11, 131\u20136.","DOI":"10.1179\/joc.1999.11.2.131"},{"key":"key\n\t\t\t\t20171013015916_R8","doi-asserted-by":"crossref","unstructured":"Safdar, A., Van Rhee, F., Henslee-Downey, J. P. et al. (2001). Candida glabrata and Candida krusei fungaemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome. Bone Marrow Transplantation28, 873\u20138.","DOI":"10.1038\/sj.bmt.1703252"},{"key":"key\n\t\t\t\t20171013015916_R9","unstructured":"National Committee for Clinical Laboratory Standards (1997). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard M27-A. NCCLS, Wayne, PA, USA."},{"key":"key\n\t\t\t\t20171013015916_R10","doi-asserted-by":"crossref","unstructured":"Rodriguez-Tudela, J. L. & Martinez-Suarez, J. V. (1995). Defining conditions for microbroth antifungal susceptibility tests: influence of RPMI and RPMI-2% glucose on the selection of endpoint criteria. Journal of Antimicrobial Chemotherapy35, 739\u201349.","DOI":"10.1093\/jac\/35.6.739"},{"key":"key\n\t\t\t\t20171013015916_R11","doi-asserted-by":"crossref","unstructured":"Rodriguez-Tudela, J. L., Berenguer, J., Martinez-Suarez, J. V. et al. (1996). Comparison of a spectrophotometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro susceptibility testing of amphotericin B, flucytosine, and fluconazole against Candida albicans. Antimicrobial Agents and Chemotherapy40, 1998\u20132003.","DOI":"10.1128\/AAC.40.9.1998"},{"key":"key\n\t\t\t\t20171013015916_R12","doi-asserted-by":"crossref","unstructured":"Wingard, J. R., Merz, W. G., Rinaldi, M. G. et al. (1991). Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. New England Journal of Medicine325, 1274\u20137.","DOI":"10.1056\/NEJM199110313251803"},{"key":"key\n\t\t\t\t20171013015916_R13","unstructured":"Jarque, I., Saavedra, S., Martin, G. et al. (2000). Delay of onset of candidaemia and emergence of Candida krusei fungaemia in haematologic patients receiving prophylactic fluconazole. Haematologica85, 441\u20133."},{"key":"key\n\t\t\t\t20171013015916_R14","doi-asserted-by":"crossref","unstructured":"Iwen, P. C., Kelly, D. M., Reed, E. C. et al. (1995). Invasive infection due to Candida krusei in immunocompromised patients not treated with fluconazole. Clinical Infectious Diseases20, 342\u20137.","DOI":"10.1093\/clinids\/20.2.342"},{"key":"key\n\t\t\t\t20171013015916_R15","unstructured":"Grossi, P., Farina, C., Fiocchi, R. et al. (2000). Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients. Transplantation70, 112\u20136."},{"key":"key\n\t\t\t\t20171013015916_R16","doi-asserted-by":"crossref","unstructured":"Viviani, M. A., Tortorano, A. M., Malaspina, C. et al. (1992). Surveillance and treatment of liver transplant recipients for candidiasis and aspergillosis. European Journal of Epidemiology8, 433\u20136.","DOI":"10.1007\/BF00158579"},{"key":"key\n\t\t\t\t20171013015916_R17","unstructured":"Thomalla, J. V., Steidle, C. P., Leapman, S. B. et al. (1998). Ureteral obstruction of a renal allograft secondary to Candida krusei. Transplantation Proceedings20, 551\u20134."},{"key":"key\n\t\t\t\t20171013015916_R18","unstructured":"Palacios, R., Santos, J., Romero, C. et al. (1999). [Fungaemia by Candida non albicans in patients with HIV infection]. Enfermedades Infecciosas y Microbiologia Cl\u00ednica17, 279\u201382."},{"key":"key\n\t\t\t\t20171013015916_R19","unstructured":"Laguna, F., Martinez-Suarez, J. V. & Adrados, M. (1994). [Fungaemia caused by Candida krusei in a female patient with AIDS]. Medicina Cl\u00ednica (Barcelona)103, 678."},{"key":"key\n\t\t\t\t20171013015916_R20","doi-asserted-by":"crossref","unstructured":"Talwar, P., Chakrabarti, A., Chawla, A. et al. (1990). Fungal diarrhoea: association of different fungi and seasonal variation in their incidence. Mycopathologia110, 101\u20135.","DOI":"10.1007\/BF00446998"},{"key":"key\n\t\t\t\t20171013015916_R21","doi-asserted-by":"crossref","unstructured":"Ponnuvel, K. M., Rajkumar, R., Menon, T. et al. (1996). Role of Candida in indirect pathogenesis of antibiotic associated diarrhoea in infants. Mycopathologia135, 145\u20137.","DOI":"10.1007\/BF00632335"},{"key":"key\n\t\t\t\t20171013015916_R22","doi-asserted-by":"crossref","unstructured":"Pfaller, M. A., Messer, S. A., Houston, A. et al. (1998). National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species. Diagnostic Microbiology and Infectious Disease31, 289\u201396.","DOI":"10.1016\/S0732-8893(97)00245-9"},{"key":"key\n\t\t\t\t20171013015916_R23","doi-asserted-by":"crossref","unstructured":"Hope, W., Morton, A. & Eisen, D. P. (2002). Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use. Journal of Hospital Infection50, 56\u201365.","DOI":"10.1053\/jhin.2001.1131"},{"key":"key\n\t\t\t\t20171013015916_R24","doi-asserted-by":"crossref","unstructured":"Abi-Said, D., Anaissie, E., Uzun, O. et al. (1997). The epidemiology of haematogenous candidiasis caused by different Candida species. Clinical Infectious Diseases24, 1122\u20138.","DOI":"10.1086\/513663"},{"key":"key\n\t\t\t\t20171013015916_R25","doi-asserted-by":"crossref","unstructured":"Goldman, M., Pottage, J. C., Jr & Weaver, D. C. (1993). Candida krusei fungaemia. Report of 4 cases and review of the literature. Medicine (Baltimore)72, 143\u201350.","DOI":"10.1097\/00005792-199305000-00002"},{"key":"key\n\t\t\t\t20171013015916_R26","doi-asserted-by":"crossref","unstructured":"Merz, W. G., Karp, J. E., Schron, D. et al. (1986). Increased incidence of fungaemia caused by Candida krusei. Journal of Clinical Microbiology24, 581\u20134.","DOI":"10.1128\/JCM.24.4.581-584.1986"},{"key":"key\n\t\t\t\t20171013015916_R27","doi-asserted-by":"crossref","unstructured":"Winston, D. J., Chandrasekar, P. H., Lazarus, H. M. et al. (1993). Fluconazole prophylaxis of fungal infections in patients with acute leukaemia. Results of a randomized placebo-controlled, double-blind, multicenter trial. Annals of Internal Medicine118, 495\u2013503.","DOI":"10.7326\/0003-4819-118-7-199304010-00003"},{"key":"key\n\t\t\t\t20171013015916_R28","doi-asserted-by":"crossref","unstructured":"Goodman, J. L., Winston, D. J., Greenfield, R. A. et al. (1992). A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. New England Journal of Medicine326, 845\u201351.","DOI":"10.1056\/NEJM199203263261301"},{"key":"key\n\t\t\t\t20171013015916_R29","doi-asserted-by":"crossref","unstructured":"Slavin, M. A., Osborne, B., Adams, R. et al. (1995). Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation\u2014a prospective, randomized, double-blind study. Journal of Infectious Diseases171, 1545\u201352.","DOI":"10.1093\/infdis\/171.6.1545"},{"key":"key\n\t\t\t\t20171013015916_R30","doi-asserted-by":"crossref","unstructured":"Krcmery, V., Jr, Oravcova, E., Spanik, S. et al. (1998). Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome. Journal of Antimicrobial Chemotherapy41, 373\u201380.","DOI":"10.1093\/jac\/41.3.373"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/55\/2\/188\/2544587\/dkh532.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T09:30:50Z","timestamp":1586079050000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/55\/2\/188\/856807\/Candida-krusei-fungaemia-antifungal-susceptibility"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,1]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2005,2]]},"published-print":{"date-parts":[[2005,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkh532","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,2]]},"published":{"date-parts":[[2005,2,1]]}}}